Breakthroughs in immunotherapy, mRNA technology, and precision targeting are ushering in an era where universal cancer vaccines could render tumors vulnerable to the body's own immune cells.
Exploring how scientists are capturing HIV's elusive alpha-helical structures to design effective vaccines by targeting conformational epitopes.